IMMY logo

IMMY

Saving Lives One Diagnostic at a Time

116 employees · est. 1979 · Norman, United States

VS
Noscendo logo

Noscendo

Innovation, precision, and purpose - redefining infection diagnostics for better outcomes.

37 employees · est. 2018 · Duisburg, Germany

IMMY is the older company (1979 vs 2018); IMMY is the larger of the two.

Side-by-Side Comparison

IMMY Noscendo
Founded
1979 older 2018
Headquarters
Norman, United States Duisburg, Germany
Employees
116 larger 37
Industry
Biotechnology, Health Care, Manufacturing Biotechnology, Health Care
Funding Stage
Not tracked yet Unknown
Total Funding
Not tracked yet $5.10M
Funding Rounds
Not tracked yet 4
Services
Development and manufacturing of diagnostic tests, Distribution of diagnostic reagents, Fungal disease education DISQVER® pathogen detection system, Information for physicians, Medical discipline support, Clinical research publication
Target Customers
Healthcare professionals, Hospitals, Reference laboratories, Physicians, Health agencies Physicians, Healthcare institutions, Clinical laboratories, Medical researchers
Taxonomy
Fungal Diagnostics, Infectious Disease Diagnostics, Antifungal Stewardship, Early Detection, Healthcare Empowerment, Diagnostic Test Manufacturing, Antigen Detection, Antibody Detection, Molecular Diagnostics, PCR, Lateral Flow Assays, In Vitro Diagnostics, Reagent Kits, Healthcare Innovations, Global Health Solutions Infection Diagnostics, Metagenomic Technology, Pathogen Identification, Bloodstream Infections, Patient-Centric Care, Rapid Diagnostics, Clinical Empowerment, Medical Innovation, Precision Medicine
Website
immy.com noscendo.com
IMMY logo

About IMMY

IMMY, founded in 1979, is a U.S.-based company headquartered in Norman, Oklahoma, with a focus on biotechnology, health care, and manufacturing. The company's slogan, Saving Lives One Diagnostic at a Time, encapsulates its mission to bring diagnostics closer to patients. They specialize in developin...

Noscendo logo

About Noscendo

Noscendo, founded in 2018 and headquartered in Germany, is pioneering the field of infection diagnostics with a focus on biotechnology and healthcare. Their core innovation, the metagenomic technology DISQVER®, enables clinicians to identify pathogens with speed and accuracy, ensuring patients recei...

We will tell you when either one moves

BounceWatch watches IMMY and Noscendo for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at IMMY and Noscendo — by email.

Frequently Asked Questions

IMMY — Saving Lives One Diagnostic at a Time. Noscendo — Innovation, precision, and purpose - redefining infection diagnostics for better outcomes.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
IMMY has raised undisclosed funding while Noscendo has raised $5.10M.
IMMY and Noscendo operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare IMMY with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at IMMY on 20 Mar 2026, and Noscendo on 28 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy